From: Estimating the survival advantage based on telomere length and serum biomarkers of aging
Group (years) | LnTL | ALB (g/L) | TP (g/L) | TC (mmol/L) | TG (mmol/L) | ALT (U/L) | AST (U/L) | ALP (U/L) | GGT (U/L) | LDH (U/L) |
---|---|---|---|---|---|---|---|---|---|---|
20–29 | 0.40 | 47.85 | 73.75 | 4.10 | 0.84 | 6.00 | 14.00 | 62.00 | 14.00 | 140.00 |
30–39 | 0.29 | 47.30 | 74.45 | 4.48 | 1.04 | 10.50 | 18.00 | 70.00 | 18.50 | 143.50 |
40–49 | −0.12 | 47.00 | 74.50 | 5.12 | 1.27 | 10.00 | 16.00 | 59.00 | 21.00 | 156.00 |
50–59 | −0.47 | 45.85 | 75.10 | 5.40 | 1.58 | 12.00 | 21.00 | 70.00 | 28.50 | 157.50 |
60–69 | −0.67 | 44.65 | 70.50 | 5.79 | 1.67 | 7.50 | 17.00 | 78.50 | 20.00 | 178.00 |
70–79 | −0.56 | 44.64 | 74.40 | 6.29 | 1.75 | 9.00 | 17.00 | 81.50 | 23.00 | 172.50 |
80–89 | −0.22 | 43.50 | 71.50 | 5.56 | 1.22 | 8.00 | 19.00 | 74.00 | 19.00 | 177.00 |
N | 98 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
p | 0.677 | <0.001 | 0.446 | <0.001 | 0.009 | 0.102 | 0.002 | 0.051 | 0.014 | <0.001 |